U.S. states sue opioid-maker Indivior, alleging anticompetitive practices

WASHINGTON (Reuters) - Thirty-five U.S. states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market.